Teva Pharmaceutical Industries Ltd (TEVA) — Strategic Asset Allocation Index
Teva Pharmaceutical Industries Ltd (TEVA) has a Strategic Asset Allocation Index of 79.5% as of June 2023. Strategic assets (PP&E of ILA6.13 Billion plus long-term investments of ILA-) total ILA6.13 Billion, measured against net assets of ILA7.71 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Teva Pharmaceutical Industries Ltd balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Teva Pharmaceutical Industries Ltd Strategic Asset Allocation Index (2000–2022)
This chart shows how Teva Pharmaceutical Industries Ltd's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 79.5%, representing strategic assets of ILA6.13 Billion against net assets of ILA7.71 Billion ILA. For live market cap and overall valuation, see TEVA stock market capitalisation.
Annual Strategic Asset Allocation Index for Teva Pharmaceutical Industries Ltd (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Teva Pharmaceutical Industries Ltd from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Teva Pharmaceutical Industries Ltd for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 70.9% | ILA6.16 Billion | ILA6.16 Billion | ILA- | ILA8.69 Billion | ▲ +13.3 pp |
| 2021 | 57.6% | ILA6.48 Billion | ILA6.48 Billion | ILA- | ILA11.24 Billion | ▼ -4.4 pp |
| 2020 | 62.0% | ILA6.86 Billion | ILA6.86 Billion | ILA- | ILA11.06 Billion | ▲ +15.8 pp |
| 2019 | 46.1% | ILA6.95 Billion | ILA6.95 Billion | ILA- | ILA15.06 Billion | ▲ +2.3 pp |
| 2018 | 43.9% | ILA6.93 Billion | ILA6.87 Billion | ILA61.00 Million | ILA15.79 Billion | ▲ +5.9 pp |
| 2017 | 38.0% | ILA7.12 Billion | ILA7.04 Billion | ILA83.00 Million | ILA18.75 Billion | ▲ +15.9 pp |
| 2016 | 22.1% | ILA7.72 Billion | ILA7.44 Billion | ILA283.00 Million | ILA34.99 Billion | ▼ -2.9 pp |
| 2015 | 25.0% | ILA7.47 Billion | ILA6.02 Billion | ILA1.45 Billion | ILA29.93 Billion | ▼ -1.3 pp |
| 2014 | 26.3% | ILA6.14 Billion | ILA5.96 Billion | ILA176.00 Million | ILA23.36 Billion | ▼ -0.6 pp |
| 2013 | 26.9% | ILA6.10 Billion | ILA5.92 Billion | ILA179.00 Million | ILA22.64 Billion | ▲ +2.5 pp |
| 2012 | 24.4% | ILA5.59 Billion | ILA5.59 Billion | ILA- | ILA22.87 Billion | ▲ +0.4 pp |
| 2011 | 24.0% | ILA5.37 Billion | ILA5.37 Billion | ILA- | ILA22.34 Billion | ▲ +5.7 pp |
| 2010 | 18.3% | ILA4.03 Billion | ILA4.03 Billion | ILA- | ILA22.00 Billion | ▲ +0.4 pp |
| 2009 | 17.9% | ILA3.46 Billion | ILA3.46 Billion | ILA- | ILA19.26 Billion | ▼ -3.0 pp |
| 2008 | 20.9% | ILA3.42 Billion | ILA3.42 Billion | ILA- | ILA16.36 Billion | ▲ +3.8 pp |
| 2007 | 17.2% | ILA2.36 Billion | ILA2.36 Billion | ILA- | ILA13.76 Billion | ▼ -1.2 pp |
| 2006 | 18.4% | ILA2.06 Billion | ILA2.06 Billion | ILA- | ILA11.18 Billion | ▼ -4.1 pp |
| 2005 | 22.5% | ILA1.36 Billion | ILA1.36 Billion | ILA- | ILA6.05 Billion | ▼ -1.2 pp |
| 2004 | 23.7% | ILA1.28 Billion | ILA1.28 Billion | ILA- | ILA5.40 Billion | ▼ -1.4 pp |
| 2003 | 25.1% | ILA827.40 Million | ILA827.40 Million | ILA- | ILA3.30 Billion | ▼ -11.7 pp |
| 2002 | 36.8% | ILA675.40 Million | ILA675.40 Million | ILA- | ILA1.83 Billion | ▼ -3.3 pp |
| 2001 | 40.1% | ILA554.14 Million | ILA554.14 Million | ILA- | ILA1.38 Billion | ▼ -6.3 pp |
| 2000 | 46.3% | ILA534.14 Million | ILA534.14 Million | ILA- | ILA1.15 Billion | — |